LIGAND PHARMACEUTICAL INC (LGNXZ)
USD 0.0
(-63.33%)
USD 0.0
(-63.33%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 52.15 Million USD | 256.33% |
| 2022 | -33.36 Million USD | -158.39% |
| 2021 | 57.13 Million USD | 2014.17% |
| 2020 | -2.98 Million USD | -100.47% |
| 2019 | 629.3 Million USD | 339.09% |
| 2018 | 143.32 Million USD | 1041.45% |
| 2017 | 12.55 Million USD | 630.46% |
| 2016 | -2.36 Million USD | -101.03% |
| 2015 | 229.82 Million USD | 1862.3% |
| 2014 | 11.71 Million USD | 2.56% |
| 2013 | 11.42 Million USD | 584.72% |
| 2012 | -2.35 Million USD | -123.15% |
| 2011 | 10.17 Million USD | 198.1% |
| 2010 | -10.37 Million USD | -432.49% |
| 2009 | -1.94 Million USD | 98.01% |
| 2008 | -98.11 Million USD | -134.83% |
| 2007 | 281.68 Million USD | 232.44% |
| 2006 | -212.68 Million USD | -484.32% |
| 2005 | -36.39 Million USD | 62.27% |
| 2004 | -96.47 Million USD | -157.52% |
| 2003 | -37.46 Million USD | -14.93% |
| 2002 | -32.59 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -51.91 Million USD | -160.26% |
| 2024 Q1 | 86.13 Million USD | 373.6% |
| 2023 Q1 | 41.94 Million USD | 339.91% |
| 2023 Q3 | -10.27 Million USD | -548.6% |
| 2023 Q2 | 2.29 Million USD | -94.54% |
| 2023 Q4 | 18.18 Million USD | 277.05% |
| 2023 FY | 52.15 Million USD | 256.33% |
| 2022 Q2 | -895 Thousand USD | 94.18% |
| 2022 Q3 | 404 Thousand USD | 145.14% |
| 2022 Q1 | -15.38 Million USD | -209.68% |
| 2022 FY | -33.36 Million USD | -158.39% |
| 2022 Q4 | -17.48 Million USD | -4427.97% |
| 2021 Q1 | 18.1 Million USD | 706.57% |
| 2021 Q3 | 13.72 Million USD | -55.34% |
| 2021 Q2 | 30.72 Million USD | 69.7% |
| 2021 Q4 | -4.96 Million USD | -136.2% |
| 2021 FY | 57.13 Million USD | 2014.17% |
| 2020 Q2 | 22.08 Million USD | 191.53% |
| 2020 FY | -2.98 Million USD | -100.47% |
| 2020 Q3 | -16.52 Million USD | -174.81% |
| 2020 Q4 | -2.98 Million USD | 81.93% |
| 2020 Q1 | -24.13 Million USD | 0.0% |
| 2019 Q2 | -14.41 Million USD | -102.16% |
| 2019 FY | 629.3 Million USD | 339.09% |
| 2019 Q1 | 666.33 Million USD | 0.0% |
| 2019 Q3 | -15.25 Million USD | -5.77% |
| 2018 Q3 | 67.36 Million USD | -7.93% |
| 2018 Q2 | 73.16 Million USD | 61.58% |
| 2018 FY | 143.32 Million USD | 1041.45% |
| 2018 Q1 | 45.27 Million USD | 0.0% |
| 2017 Q2 | 6.05 Million USD | 19.28% |
| 2017 FY | 12.55 Million USD | 630.46% |
| 2017 Q3 | 8.42 Million USD | 39.09% |
| 2017 Q1 | 5.07 Million USD | 0.0% |
| 2016 Q2 | 22.55 Million USD | 70.05% |
| 2016 Q1 | 13.26 Million USD | 0.0% |
| 2016 Q3 | 1.05 Million USD | -95.34% |
| 2016 FY | -2.36 Million USD | -101.03% |
| 2015 FY | 229.82 Million USD | 1862.3% |
| 2015 Q3 | 224.53 Million USD | 895.43% |
| 2015 Q2 | 22.55 Million USD | 2775.8% |
| 2015 Q1 | -843 Thousand USD | 0.0% |
| 2014 Q3 | 1.02 Million USD | -14.15% |
| 2014 FY | 11.71 Million USD | 2.56% |
| 2014 Q1 | 2.09 Million USD | 0.0% |
| 2014 Q2 | 1.19 Million USD | -43.06% |
| 2013 Q3 | 1.96 Million USD | -67.74% |
| 2013 Q2 | 6.09 Million USD | 307.42% |
| 2013 Q1 | 1.49 Million USD | 0.0% |
| 2013 FY | 11.42 Million USD | 584.72% |
| 2012 FY | -2.35 Million USD | -123.15% |
| 2012 Q2 | -2.52 Million USD | -323.21% |
| 2012 Q3 | -194 Thousand USD | 92.33% |
| 2012 Q1 | 1.13 Million USD | 0.0% |
| 2011 Q1 | 10.03 Million USD | 0.0% |
| 2011 Q2 | -914 Thousand USD | -109.11% |
| 2011 FY | 10.17 Million USD | 198.1% |
| 2011 Q3 | -3.75 Million USD | -310.94% |
| 2010 FY | -10.37 Million USD | -432.49% |
| 2010 Q3 | -11.84 Million USD | -1333.65% |
| 2010 Q2 | 960 Thousand USD | 132.12% |
| 2010 Q1 | -2.98 Million USD | 0.0% |
| 2009 Q1 | -5.11 Million USD | 0.0% |
| 2009 FY | -1.94 Million USD | 98.01% |
| 2009 Q2 | -10.00 USD | 100.0% |
| 2009 Q3 | 1.8 Million USD | 18030100.0% |
| 2008 Q3 | -18.12 Million USD | -181.93% |
| 2008 Q2 | -6.42 Million USD | 20.1% |
| 2008 Q1 | -8.04 Million USD | 0.0% |
| 2008 FY | -98.11 Million USD | -134.83% |
| 2007 FY | 281.68 Million USD | 232.44% |
| 2007 Q1 | 274.32 Million USD | 0.0% |
| 2007 Q2 | -9.62 Million USD | -103.51% |
| 2007 Q3 | -8.57 Million USD | 10.9% |
| 2006 Q1 | -142.22 Million USD | 0.0% |
| 2006 Q2 | -15.95 Million USD | 88.78% |
| 2006 Q3 | -14.91 Million USD | 6.52% |
| 2006 FY | -212.68 Million USD | -484.32% |
| 2005 FY | -36.39 Million USD | 62.27% |
| 2005 Q2 | -8.92 Million USD | 51.69% |
| 2005 Q1 | -18.47 Million USD | 0.0% |
| 2005 Q3 | -6.28 Million USD | 29.62% |
| 2004 FY | -96.47 Million USD | -157.52% |
| 2004 Q1 | -13.13 Million USD | 0.0% |
| 2004 Q2 | -14.21 Million USD | -8.2% |
| 2003 FY | -37.46 Million USD | -14.93% |
| 2003 Q2 | -11.99 Million USD | 40.96% |
| 2003 Q1 | -20.32 Million USD | 0.0% |
| 2003 Q3 | -11.08 Million USD | 7.59% |
| 2002 Q3 | -7.04 Million USD | 0.0% |
| 2002 FY | -32.59 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -3703.18 USD | 1408457.142% |
| Allstar Health Brands, Inc. | -499.34 Thousand USD | 10544.524% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 69.18 Million USD | 24.618% |
| Café Serendipity Holdings, Inc. | -750.15 Thousand USD | 7052.411% |
| Decision Diagnostics Corp. | - USD | -Infinity% |
| Health Advance Inc. | -49.02 Thousand USD | 106488.968% |
| HealthWarehouse.com, Inc. | -1.77 Million USD | 3040.606% |
| MedGen, Inc. | -15.54 USD | 335611425.611% |
| Omni Health, Inc. | 1.26 Million USD | -4020.764% |
| Oxford Investments Holdings Inc. | -299.1 Thousand USD | 17536.803% |
| Pineapple, Inc. | -1.47 Million USD | 3629.557% |
| ScripsAmerica, Inc. | -4.73 Million USD | 1202.378% |